Blood-Based Biomarkers for Neuroprognostication in Acute Brain Injury
- PMID: 37751855
- PMCID: PMC10668565
- DOI: 10.1055/s-0043-1775764
Blood-Based Biomarkers for Neuroprognostication in Acute Brain Injury
Abstract
Acute brain injury causes loss of functionality in patients that often is devastating. Predicting the degree of functional loss and overall prognosis requires a multifaceted approach to help patients, and more so their families, make important decisions regarding plans and goals of care. A variety of blood-based markers have been studied as one aspect of this determination. In this review, we discuss CNS-derived and systemic markers that have been studied for neuroprognostication purposes. We discuss the foundation of each protein, the conditions in which it has been studied, and how the literature has used these markers for interpretation. We also discuss challenges to using each marker in each section as well.
Thieme. All rights reserved.
Conflict of interest statement
None declared.
References
-
- Scolletta S, Donadello K, Santonocito C, Franchi F, Taccone FS. Biomarkers as predictors of outcome after cardiac arrest. Expert Rev Clin Pharmacol 2012;5(06):687–699 - PubMed
-
- Roine RO, Somer H, Kaste M, Viinikka L, Karonen S-L. Neurological outcome after out-of-hospital cardiac arrest. Prediction by cerebrospinal fluid enzyme analysis. Arch Neurol 1989;46(07):753–756 - PubMed
-
- Panchal AR, Bartos JA, Cabañas JG, et al.; Adult Basic and Advanced Life Support Writing Group. Part 3: Adult basic and advanced life support: 2020 American Heart Association Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2020;142(16, suppl 2):S366–S468 - PubMed
